Glenn Chertow, MD
Enriched profileNorman S. Coplon/Satellite Healthcare Professor of Medicine, Chief, Division of Nephrology, Associate Chair (Fellowship Programs), Department of Medicine at Stanford University School of Medicine · Stanford University School of Medicine
Glenn Chertow is Norman S. Coplon/Satellite Healthcare Professor of Medicine, Chief, Division of Nephrology, Associate Chair (Fellowship Programs), Department of Medicine at Stanford University School of Medicine at Stanford University School of Medicine. OpenAlex indexes 1,323 publications with 109,191 citations (h-index 155); ClinicalTrials.gov lists 9 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Nephrology profiles in the findmyKOL directory.
Data verified 18 Oct 2026
Overview
Updated 18 Oct 2026
Glenn Chertow, MD, is Norman S. Coplon/Satellite Healthcare Professor of Medicine, Chief, Division of Nephrology, Associate Chair (Fellowship Programs), Department of Medicine at Stanford University School of Medicine. The public record shows 1,323 publications with 109,191 citations (h-index 155), centered on Dialysis and Renal Disease Management, Chronic Kidney Disease and Diabetes, Acute Kidney Injury Research. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 27 companies, 10 NIH-funded awards (2001–2026).
- Most recent indexed publication: 2026 · Diabetes, obesity & metabolism
- Top research focus: Dialysis and Renal Disease Management
- 9 registered trials on ClinicalTrials.gov
- Open Payments reporting from 27 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 82 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 705.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:
- SARS-COV-2 Screening in Dialysis Facilities
Sponsor: Stanford University
- Sit Less, Interact and Move More (SLIMM) 2 Study
Sponsor: Srinvasan Beddhu
Industry payments
Updated 18 Oct 2026
27 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- AKEBIA THERAPEUTICS INCProgram year202513 payments$89,878openpaymentsdata.cms.gov ↗
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year202517 payments$82,483openpaymentsdata.cms.gov ↗
- AstraZeneca Pharmaceuticals LPProgram year202524 payments$77,441openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
48.3%Angiotensin receptor blocker (ARB)10.6%Losartan Potassium64%Valsartan24%Telmisartan12%Part D<11 patientsCalcium channel blocker9.6%Amlodipine Besylate85%Nifedipine Er15%Part D<11 patients+ 8 more classes in this area
Metabolism & gastrointestinal
38.3%SGLT2 inhibitor25%Farxiga80%Jardiance12%Dapagliflozin9%Part D≥41 patientsGLP-1 receptor agonist8.7%Mounjaro47%Ozempic30%Trulicity23%Part D<11 patients+ 3 more classes in this area
Blood & clotting
4.8%Solutions for parenteral nutrition4.8%Calcium Acetate100%Part D≥21 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 18 Oct 2026
10 NIH research awards on record, funded 2001–2026 per NIH RePORTER. The latest:
Congress activity
Updated 18 Oct 2026
6 congress contributions (2021–2022) across ADA per OpenAlex. The most recent:
- 866-P: Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis from the DAPA-CKD Study
ADA Scientific Sessions
ADA2022Co-authorPoster - 1028-P: Inside CKD: Modeling the Clinical and Economic Impact of Routine Screening for Albuminuria in People with Type 2 Diabetes
ADA Scientific Sessions
ADA2021Co-authorPoster - 1051-P: Inside CKD: Modeling the Future Global Burden of Chronic Kidney Disease in Patients with Type 2 Diabetes
ADA Scientific Sessions
ADA2021Co-authorPoster
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 18 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Prevalence, Incidence and Mortality of Chronic Kidney Disease in Type 1 and Type 2 Diabetes-A Nationwide Danish Register-Based Cohort Study.
Diabetes, obesity & metabolism
Article2026 - Calcified amorphous tumor in a patient receiving peritoneal dialysis with severe, treatment-refractory hyperphosphatemia.
Peritoneal dialysis international
Article2026 - Raising the Profile of Collaborative Biostatisticians in Team Science.
Journal of general internal medicine
Editorial2026 - More Evidence, More Options, More Questions.
Journal of the American Society of Nephrology
Article2026
Most-cited works
by citation count (OpenAlex)- 01Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationArticle11,376 citations2004
- 02Dapagliflozin in Patients with Chronic Kidney DiseaseArticle5,557 citations2020
- 03Acute Kidney Injury, Mortality, Length of Stay, and Costs in Hospitalized PatientsArticle3,410 citations2005
- 04Mineral Metabolism, Mortality, and Morbidity in Maintenance HemodialysisArticle2,687 citations2004
- 05K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney diseaseArticle2,531 citations2003
Network
Updated 18 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 18 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/glenn-chertow-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MPH from Harvard1995verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthpolicy.fsi.stanford.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthpolicy.fsi.stanford.edu ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.stanford.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.stanford.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kidney.org ↗
- Board of Directors
Kidney Disease: Improving Global Outcomes (KDIGO)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kidney.org ↗ - Public Policy Board
American Society of Nephrology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →kidney.org ↗ - Associate Editor
American Journal of Nephrology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →karger.com ↗ - Associate Editor
Journal of the American Society of Nephrology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →kidney.org ↗ - Co-Editor
Brenner and Rector's The Kidney (9th edition)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthpolicy.fsi.stanford.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kidney.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.stanford.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kidney.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kidney.org ↗
Secondary affiliations
appointments beyond the home institution- Bio-X Affiliated Faculty
Stanford University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →biox.stanford.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sdrc.stanford.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Heidenreich, MD
Stanford University School of Medicine
Alan Schatzberg, MD
Stanford University School of Medicine
Euan Ashley, MD
Stanford University School of Medicine
Mark Pegram, MD
Stanford University School of Medicine
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Toni Choueiri, MD
Dana-Farber Cancer Institute
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Fred Saad, MD
Centre hospitalier de l'Université de Montréal (CHUM)